Experts are working on novel immune-enhancing therapies called host-directed therapies to use the body's own immune system to target tuberculosis, with hopes that they could tackle even the drug-resistant forms of the disease. ...
3 hours ago
0
0
One potential underlying cause of symptoms in individuals with depression is an emotion-processing bias which causes them to have a stronger response to negative information more so than positive. While prior research has ...
Apr 17, 2024
0
27
Since Yale researchers first observed the ability of the anesthetic ketamine to dramatically improve symptoms in many patients with treatment-resistant depression more than two decades ago, the drug has provided a powerful ...
Apr 17, 2024
0
11
A faster and vastly more effective treatment for drug-resistant tuberculosis is being rolled out in the Asia-Pacific region, raising hopes of a "new era" in tackling one of the world's deadliest infectious diseases.
Apr 12, 2024
0
20
The A*STAR Infectious Diseases Labs (A*STAR ID Labs) and the Hackensack Meridian Health Center for Discovery and Innovation have teamed up to shed light on a concerning health issue—infections caused by a type of bacteria ...
Apr 2, 2024
0
21
Lung cancer is the leading cause of cancer-related death worldwide. Improved understanding of driver mutations of non-small cell lung cancer (NSCLC) has led to more biomarker-directed treatment for patients with advanced ...
Mar 27, 2024
0
0
Urinary tract infections (UTIs) caused by E. coli from aged care facilities show higher resistance to antibiotics compared to cases collected from hospitals and the wider community, find researchers from UNSW Sydney.
Mar 21, 2024
0
0
Patients with some types of lymphoma that become resistant to standard treatments may benefit from a therapy that University of Wisconsin–Madison researchers are evaluating after they discovered a key process that fuels ...
Mar 16, 2024
0
48
A cellular profiling method called dynamic BH3 profiling (DBP), developed by investigators at Dana-Farber Cancer Institute, has the potential to help guide personalized treatment for relapsed, drug-resistant acute myeloid ...
Mar 6, 2024
0
0
Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, according to researchers ...
Feb 27, 2024
0
3
